{ "sections": [ { "title": "Headache Disorders", "requirement_evaluations": [ { "requirement_id": "R1", "applicable": true, "applicability_reasoning": "The content section is discussing the role of specific polypeptides in migraine pathogenesis, and providing specific studies and findings related to this.", "score": 0.0, "confidence": 0.90, "evidence": "The section mentions a research group and the institution directly by noting a Danish research group led by Dr. Messoud Ashina.", "reasoning": "Direct mention of a research group and leader violates the requirement to not mention the research group or institution directly in the content.", "overlap_notes": "None noted." }, { "requirement_id": "R4", "applicable": true, "applicability_reasoning": "The section focuses on the implications of specific studies regarding headache disorders related to pituitary adenylate cyclase-activating polypeptide.", "score": 0.75, "confidence": 0.85, "evidence": "The section describes migraine-like attacks and related treatments involving monoclonal antibodies, pertinent to headache disorders.", "reasoning": "The section effectively focuses on relevant studies about migraine pathogenesis, though could be more structured to highlight clinical significance.", "overlap_notes": "Relevant content is present but could be structured for focus on specific clinical significance." } ], "meta_notes": "The section discusses significant research related to headache disorders and potential treatments. There's an inappropriate mention of a research group, and while it focuses on study implications, it could benefit from clearer structure towards clinical significance." } ] }